nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Propranolol—migraine	0.406	1	CrCtD
Esmolol—ADRB2—Timolol—migraine	0.0555	0.266	CbGbCtD
Esmolol—ADRB1—Timolol—migraine	0.0547	0.262	CbGbCtD
Esmolol—Bevantolol—Verapamil—migraine	0.0519	0.174	CrCrCtD
Esmolol—ADRB2—Propranolol—migraine	0.0495	0.237	CbGbCtD
Esmolol—ADRB1—Propranolol—migraine	0.0487	0.234	CbGbCtD
Esmolol—Metipranolol—Propranolol—migraine	0.0276	0.0923	CrCrCtD
Esmolol—Bevantolol—Propranolol—migraine	0.0235	0.0786	CrCrCtD
Esmolol—Acebutolol—Propranolol—migraine	0.0235	0.0786	CrCrCtD
Esmolol—Betaxolol—Propranolol—migraine	0.0235	0.0786	CrCrCtD
Esmolol—Bisoprolol—Propranolol—migraine	0.0219	0.0733	CrCrCtD
Esmolol—Metoprolol—Propranolol—migraine	0.0194	0.0648	CrCrCtD
Esmolol—Alprenolol—Propranolol—migraine	0.0194	0.0648	CrCrCtD
Esmolol—Practolol—Propranolol—migraine	0.0194	0.0648	CrCrCtD
Esmolol—Oxprenolol—Propranolol—migraine	0.0194	0.0648	CrCrCtD
Esmolol—Atenolol—Propranolol—migraine	0.0183	0.0613	CrCrCtD
Esmolol—Pindolol—Propranolol—migraine	0.0166	0.0555	CrCrCtD
Esmolol—Propafenone—Propranolol—migraine	0.0146	0.0487	CrCrCtD
Esmolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00103	0.0401	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00103	0.0401	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000748	0.0291	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000732	0.0285	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000695	0.0271	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.00068	0.0265	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000629	0.0245	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000615	0.0239	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000584	0.0228	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000572	0.0223	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000453	0.0176	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000443	0.0173	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000436	0.017	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000427	0.0166	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000421	0.0164	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000412	0.016	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.00041	0.016	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000394	0.0154	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000381	0.0148	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000373	0.0145	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000369	0.0144	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000367	0.0143	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000361	0.0141	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000359	0.014	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000357	0.0139	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000357	0.0139	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000354	0.0138	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000349	0.0136	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000349	0.0136	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000346	0.0135	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.00031	0.0121	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000303	0.0118	CbGpPWpGaD
Esmolol—Pindolol—HTR1B—migraine	0.000299	0.271	CrCbGaD
Esmolol—Alprenolol—HTR1A—migraine	0.000275	0.249	CrCbGaD
Esmolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000258	0.0101	CbGpPWpGaD
Esmolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000253	0.00984	CbGpPWpGaD
Esmolol—Pindolol—HTR1A—migraine	0.000237	0.215	CrCbGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000234	0.00909	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000228	0.0089	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000217	0.00846	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000212	0.00827	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000178	0.00693	CbGpPWpGaD
Esmolol—Propranolol—HTR1B—migraine	0.000163	0.148	CrCbGaD
Esmolol—ADRB2—GPCRs, Other—HTR7—migraine	0.00016	0.00624	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000149	0.0058	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000146	0.00567	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000144	0.00562	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000141	0.0055	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000137	0.00533	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000134	0.00522	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000134	0.00521	CbGpPWpGaD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000132	0.0022	CcSEcCtD
Esmolol—Agitation—Verapamil—migraine	0.000132	0.0022	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000131	0.00511	CbGpPWpGaD
Esmolol—Angioedema—Verapamil—migraine	0.000131	0.00219	CcSEcCtD
Esmolol—Drowsiness—Valproic Acid—migraine	0.00013	0.00218	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.00013	0.00505	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.00013	0.00505	CbGpPWpGaD
Esmolol—Nasal congestion—Topiramate—migraine	0.000129	0.00216	CcSEcCtD
Esmolol—Propranolol—HTR1A—migraine	0.000129	0.117	CrCbGaD
Esmolol—Feeling abnormal—Amitriptyline—migraine	0.000129	0.00215	CcSEcCtD
Esmolol—Syncope—Verapamil—migraine	0.000129	0.00215	CcSEcCtD
Esmolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000128	0.00498	CbGpPWpGaD
Esmolol—Bronchospasm—Timolol—migraine	0.000128	0.00214	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000127	0.00494	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000127	0.00494	CbGpPWpGaD
Esmolol—Angina pectoris—Timolol—migraine	0.000127	0.00212	CcSEcCtD
Esmolol—Loss of consciousness—Verapamil—migraine	0.000126	0.00211	CcSEcCtD
Esmolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000125	0.00487	CbGpPWpGaD
Esmolol—Nasopharyngitis—Gabapentin—migraine	0.000125	0.00209	CcSEcCtD
Esmolol—Nervous system disorder—Propranolol—migraine	0.000125	0.00209	CcSEcCtD
Esmolol—Convulsion—Verapamil—migraine	0.000124	0.00208	CcSEcCtD
Esmolol—Urticaria—Amitriptyline—migraine	0.000124	0.00208	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000124	0.00481	CbGpPWpGaD
Esmolol—Skin disorder—Propranolol—migraine	0.000124	0.00207	CcSEcCtD
Esmolol—Body temperature increased—Amitriptyline—migraine	0.000124	0.00207	CcSEcCtD
Esmolol—Chest pain—Verapamil—migraine	0.000122	0.00204	CcSEcCtD
Esmolol—Dysuria—Timolol—migraine	0.000121	0.00203	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000121	0.00471	CbGpPWpGaD
Esmolol—Dry mouth—Verapamil—migraine	0.000119	0.002	CcSEcCtD
Esmolol—Bronchospasm—Gabapentin—migraine	0.000119	0.00199	CcSEcCtD
Esmolol—Bradycardia—Valproic Acid—migraine	0.000119	0.00199	CcSEcCtD
Esmolol—Confusional state—Verapamil—migraine	0.000118	0.00197	CcSEcCtD
Esmolol—Angina pectoris—Gabapentin—migraine	0.000118	0.00197	CcSEcCtD
Esmolol—Sweating increased—Gabapentin—migraine	0.000118	0.00197	CcSEcCtD
Esmolol—Rhinitis—Valproic Acid—migraine	0.000117	0.00196	CcSEcCtD
Esmolol—Oedema—Verapamil—migraine	0.000117	0.00196	CcSEcCtD
Esmolol—Pharyngitis—Valproic Acid—migraine	0.000116	0.00194	CcSEcCtD
Esmolol—Urinary tract disorder—Valproic Acid—migraine	0.000115	0.00193	CcSEcCtD
Esmolol—Shock—Verapamil—migraine	0.000115	0.00193	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000115	0.00448	CbGpPWpGaD
Esmolol—Urethral disorder—Valproic Acid—migraine	0.000114	0.00192	CcSEcCtD
Esmolol—Paraesthesia—Propranolol—migraine	0.000114	0.00191	CcSEcCtD
Esmolol—Dyspnoea—Propranolol—migraine	0.000113	0.0019	CcSEcCtD
Esmolol—Hyperhidrosis—Verapamil—migraine	0.000113	0.00189	CcSEcCtD
Esmolol—Dysuria—Gabapentin—migraine	0.000113	0.00189	CcSEcCtD
Esmolol—Somnolence—Propranolol—migraine	0.000113	0.00189	CcSEcCtD
Esmolol—Visual impairment—Valproic Acid—migraine	0.000113	0.00188	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000112	0.00438	CbGpPWpGaD
Esmolol—Irritability—Topiramate—migraine	0.000112	0.00188	CcSEcCtD
Esmolol—ADRB2—GPCRs, Other—HTR2A—migraine	0.000112	0.00437	CbGpPWpGaD
Esmolol—Asthenia—Amitriptyline—migraine	0.000112	0.00188	CcSEcCtD
Esmolol—Dyspepsia—Propranolol—migraine	0.000112	0.00187	CcSEcCtD
Esmolol—Urinary retention—Topiramate—migraine	0.000112	0.00187	CcSEcCtD
Esmolol—Decreased appetite—Propranolol—migraine	0.000111	0.00185	CcSEcCtD
Esmolol—Pruritus—Amitriptyline—migraine	0.000111	0.00185	CcSEcCtD
Esmolol—Gastrointestinal disorder—Propranolol—migraine	0.00011	0.00184	CcSEcCtD
Esmolol—Fatigue—Propranolol—migraine	0.00011	0.00183	CcSEcCtD
Esmolol—Hypotension—Verapamil—migraine	0.000109	0.00183	CcSEcCtD
Esmolol—Constipation—Propranolol—migraine	0.000109	0.00182	CcSEcCtD
Esmolol—Pain—Propranolol—migraine	0.000109	0.00182	CcSEcCtD
Esmolol—Drowsiness—Gabapentin—migraine	0.000108	0.0018	CcSEcCtD
Esmolol—Acute coronary syndrome—Gabapentin—migraine	0.000106	0.00178	CcSEcCtD
Esmolol—Angiopathy—Valproic Acid—migraine	0.000106	0.00177	CcSEcCtD
Esmolol—Bradycardia—Timolol—migraine	0.000106	0.00177	CcSEcCtD
Esmolol—Neuropathy peripheral—Gabapentin—migraine	0.000106	0.00177	CcSEcCtD
Esmolol—Myocardial infarction—Gabapentin—migraine	0.000106	0.00177	CcSEcCtD
Esmolol—Nasopharyngitis—Topiramate—migraine	0.000105	0.00176	CcSEcCtD
Esmolol—Paraesthesia—Verapamil—migraine	0.000105	0.00176	CcSEcCtD
Esmolol—Chills—Valproic Acid—migraine	0.000105	0.00175	CcSEcCtD
Esmolol—Dyspnoea—Verapamil—migraine	0.000104	0.00175	CcSEcCtD
Esmolol—Rhinitis—Timolol—migraine	0.000104	0.00174	CcSEcCtD
Esmolol—Somnolence—Verapamil—migraine	0.000104	0.00174	CcSEcCtD
Esmolol—Dizziness—Amitriptyline—migraine	0.000103	0.00173	CcSEcCtD
Esmolol—Dyspepsia—Verapamil—migraine	0.000103	0.00172	CcSEcCtD
Esmolol—Mental disorder—Valproic Acid—migraine	0.000102	0.00171	CcSEcCtD
Esmolol—Urticaria—Propranolol—migraine	0.000101	0.00169	CcSEcCtD
Esmolol—Fatigue—Verapamil—migraine	0.000101	0.00169	CcSEcCtD
Esmolol—Body temperature increased—Propranolol—migraine	0.000101	0.00168	CcSEcCtD
Esmolol—Visual impairment—Timolol—migraine	0.0001	0.00168	CcSEcCtD
Esmolol—Constipation—Verapamil—migraine	0.0001	0.00167	CcSEcCtD
Esmolol—Pain—Verapamil—migraine	0.0001	0.00167	CcSEcCtD
Esmolol—Dysgeusia—Valproic Acid—migraine	9.96e-05	0.00167	CcSEcCtD
Esmolol—Vomiting—Amitriptyline—migraine	9.93e-05	0.00166	CcSEcCtD
Esmolol—Angina pectoris—Topiramate—migraine	9.91e-05	0.00166	CcSEcCtD
Esmolol—Sweating increased—Topiramate—migraine	9.91e-05	0.00166	CcSEcCtD
Esmolol—Bradycardia—Gabapentin—migraine	9.86e-05	0.00165	CcSEcCtD
Esmolol—Headache—Amitriptyline—migraine	9.79e-05	0.00164	CcSEcCtD
Esmolol—Abdominal discomfort—Topiramate—migraine	9.76e-05	0.00163	CcSEcCtD
Esmolol—Rhinitis—Gabapentin—migraine	9.71e-05	0.00162	CcSEcCtD
Esmolol—Cardiac disorder—Timolol—migraine	9.65e-05	0.00161	CcSEcCtD
Esmolol—Feeling abnormal—Verapamil—migraine	9.64e-05	0.00161	CcSEcCtD
Esmolol—Pharyngitis—Gabapentin—migraine	9.61e-05	0.00161	CcSEcCtD
Esmolol—Urinary tract disorder—Gabapentin—migraine	9.56e-05	0.0016	CcSEcCtD
Esmolol—Dysuria—Topiramate—migraine	9.52e-05	0.00159	CcSEcCtD
Esmolol—Urethral disorder—Gabapentin—migraine	9.49e-05	0.00159	CcSEcCtD
Esmolol—Angiopathy—Timolol—migraine	9.43e-05	0.00158	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR1D—migraine	9.42e-05	0.00367	CbGpPWpGaD
Esmolol—Agitation—Valproic Acid—migraine	9.34e-05	0.00156	CcSEcCtD
Esmolol—Visual impairment—Gabapentin—migraine	9.33e-05	0.00156	CcSEcCtD
Esmolol—Urticaria—Verapamil—migraine	9.3e-05	0.00156	CcSEcCtD
Esmolol—Angioedema—Valproic Acid—migraine	9.29e-05	0.00155	CcSEcCtD
Esmolol—Nausea—Amitriptyline—migraine	9.28e-05	0.00155	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR1D—migraine	9.21e-05	0.00359	CbGpPWpGaD
Esmolol—Asthenia—Propranolol—migraine	9.13e-05	0.00153	CcSEcCtD
Esmolol—Mental disorder—Timolol—migraine	9.11e-05	0.00152	CcSEcCtD
Esmolol—Erythema—Timolol—migraine	9.05e-05	0.00151	CcSEcCtD
Esmolol—Cardiac disorder—Gabapentin—migraine	8.98e-05	0.0015	CcSEcCtD
Esmolol—Neuropathy peripheral—Topiramate—migraine	8.89e-05	0.00149	CcSEcCtD
Esmolol—Dysgeusia—Timolol—migraine	8.86e-05	0.00148	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR2B—migraine	8.75e-05	0.00341	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.74e-05	0.0034	CbGpPWpGaD
Esmolol—Chills—Gabapentin—migraine	8.69e-05	0.00145	CcSEcCtD
Esmolol—Chest pain—Valproic Acid—migraine	8.65e-05	0.00145	CcSEcCtD
Esmolol—Anxiety—Valproic Acid—migraine	8.63e-05	0.00144	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	8.6e-05	0.00144	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR2B—migraine	8.56e-05	0.00333	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.55e-05	0.00333	CbGpPWpGaD
Esmolol—Mental disorder—Gabapentin—migraine	8.48e-05	0.00142	CcSEcCtD
Esmolol—Dry mouth—Valproic Acid—migraine	8.46e-05	0.00142	CcSEcCtD
Esmolol—Erythema—Gabapentin—migraine	8.43e-05	0.00141	CcSEcCtD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.42e-05	0.00328	CbGpPWpGaD
Esmolol—Dizziness—Propranolol—migraine	8.41e-05	0.00141	CcSEcCtD
Esmolol—Asthenia—Verapamil—migraine	8.4e-05	0.0014	CcSEcCtD
Esmolol—Confusional state—Valproic Acid—migraine	8.37e-05	0.0014	CcSEcCtD
Esmolol—Oedema—Valproic Acid—migraine	8.3e-05	0.00139	CcSEcCtD
Esmolol—Bradycardia—Topiramate—migraine	8.29e-05	0.00139	CcSEcCtD
Esmolol—Pruritus—Verapamil—migraine	8.28e-05	0.00139	CcSEcCtD
Esmolol—Angioedema—Timolol—migraine	8.27e-05	0.00138	CcSEcCtD
Esmolol—Dysgeusia—Gabapentin—migraine	8.25e-05	0.00138	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.23e-05	0.00321	CbGpPWpGaD
Esmolol—Rhinitis—Topiramate—migraine	8.17e-05	0.00137	CcSEcCtD
Esmolol—Nervous system disorder—Valproic Acid—migraine	8.14e-05	0.00136	CcSEcCtD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.13e-05	0.00317	CbGpPWpGaD
Esmolol—Syncope—Timolol—migraine	8.12e-05	0.00136	CcSEcCtD
Esmolol—Vomiting—Propranolol—migraine	8.09e-05	0.00135	CcSEcCtD
Esmolol—Pharyngitis—Topiramate—migraine	8.08e-05	0.00135	CcSEcCtD
Esmolol—Skin disorder—Valproic Acid—migraine	8.06e-05	0.00135	CcSEcCtD
Esmolol—Urinary tract disorder—Topiramate—migraine	8.04e-05	0.00135	CcSEcCtD
Esmolol—Hyperhidrosis—Valproic Acid—migraine	8.02e-05	0.00134	CcSEcCtD
Esmolol—Urethral disorder—Topiramate—migraine	7.98e-05	0.00134	CcSEcCtD
Esmolol—Loss of consciousness—Timolol—migraine	7.95e-05	0.00133	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.95e-05	0.0031	CbGpPWpGaD
Esmolol—Anorexia—Valproic Acid—migraine	7.91e-05	0.00132	CcSEcCtD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.91e-05	0.00308	CbGpPWpGaD
Esmolol—Visual impairment—Topiramate—migraine	7.85e-05	0.00131	CcSEcCtD
Esmolol—Hypotension—Valproic Acid—migraine	7.75e-05	0.0013	CcSEcCtD
Esmolol—Agitation—Gabapentin—migraine	7.74e-05	0.0013	CcSEcCtD
Esmolol—Dizziness—Verapamil—migraine	7.74e-05	0.00129	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.74e-05	0.00301	CbGpPWpGaD
Esmolol—Chest pain—Timolol—migraine	7.7e-05	0.00129	CcSEcCtD
Esmolol—Angioedema—Gabapentin—migraine	7.7e-05	0.00129	CcSEcCtD
Esmolol—Anxiety—Timolol—migraine	7.68e-05	0.00128	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	7.65e-05	0.00128	CcSEcCtD
Esmolol—Cardiac disorder—Topiramate—migraine	7.56e-05	0.00126	CcSEcCtD
Esmolol—Flushing—Topiramate—migraine	7.56e-05	0.00126	CcSEcCtD
Esmolol—Syncope—Gabapentin—migraine	7.56e-05	0.00126	CcSEcCtD
Esmolol—Nausea—Propranolol—migraine	7.56e-05	0.00126	CcSEcCtD
Esmolol—Dry mouth—Timolol—migraine	7.54e-05	0.00126	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.49e-05	0.00292	CbGpPWpGaD
Esmolol—Paraesthesia—Valproic Acid—migraine	7.45e-05	0.00125	CcSEcCtD
Esmolol—Confusional state—Timolol—migraine	7.45e-05	0.00125	CcSEcCtD
Esmolol—Vomiting—Verapamil—migraine	7.44e-05	0.00124	CcSEcCtD
Esmolol—Loss of consciousness—Gabapentin—migraine	7.41e-05	0.00124	CcSEcCtD
Esmolol—Dyspnoea—Valproic Acid—migraine	7.4e-05	0.00124	CcSEcCtD
Esmolol—Angiopathy—Topiramate—migraine	7.39e-05	0.00124	CcSEcCtD
Esmolol—Oedema—Timolol—migraine	7.39e-05	0.00124	CcSEcCtD
Esmolol—Somnolence—Valproic Acid—migraine	7.38e-05	0.00123	CcSEcCtD
Esmolol—Headache—Verapamil—migraine	7.33e-05	0.00123	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.33e-05	0.00285	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	7.32e-05	0.00285	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	7.32e-05	0.00285	CbGpPWpGaD
Esmolol—Chills—Topiramate—migraine	7.31e-05	0.00122	CcSEcCtD
Esmolol—Dyspepsia—Valproic Acid—migraine	7.3e-05	0.00122	CcSEcCtD
Esmolol—Convulsion—Gabapentin—migraine	7.3e-05	0.00122	CcSEcCtD
Esmolol—Shock—Timolol—migraine	7.27e-05	0.00122	CcSEcCtD
Esmolol—Nervous system disorder—Timolol—migraine	7.24e-05	0.00121	CcSEcCtD
Esmolol—Decreased appetite—Valproic Acid—migraine	7.21e-05	0.00121	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.21e-05	0.00281	CbGpPWpGaD
Esmolol—Chest pain—Gabapentin—migraine	7.17e-05	0.0012	CcSEcCtD
Esmolol—Skin disorder—Timolol—migraine	7.17e-05	0.0012	CcSEcCtD
Esmolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	7.16e-05	0.00279	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	7.16e-05	0.00279	CbGpPWpGaD
Esmolol—Gastrointestinal disorder—Valproic Acid—migraine	7.16e-05	0.0012	CcSEcCtD
Esmolol—Fatigue—Valproic Acid—migraine	7.15e-05	0.0012	CcSEcCtD
Esmolol—Anxiety—Gabapentin—migraine	7.15e-05	0.0012	CcSEcCtD
Esmolol—Hyperhidrosis—Timolol—migraine	7.14e-05	0.00119	CcSEcCtD
Esmolol—Mental disorder—Topiramate—migraine	7.14e-05	0.00119	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	7.13e-05	0.00119	CcSEcCtD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.12e-05	0.00277	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.1e-05	0.00277	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.1e-05	0.00277	CbGpPWpGaD
Esmolol—Pain—Valproic Acid—migraine	7.1e-05	0.00119	CcSEcCtD
Esmolol—Constipation—Valproic Acid—migraine	7.1e-05	0.00119	CcSEcCtD
Esmolol—Erythema—Topiramate—migraine	7.09e-05	0.00119	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.05e-05	0.00275	CbGpPWpGaD
Esmolol—Anorexia—Timolol—migraine	7.04e-05	0.00118	CcSEcCtD
Esmolol—Dry mouth—Gabapentin—migraine	7.02e-05	0.00117	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.97e-05	0.00271	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.97e-05	0.00271	CbGpPWpGaD
Esmolol—Nausea—Verapamil—migraine	6.95e-05	0.00116	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.95e-05	0.00271	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.95e-05	0.00271	CbGpPWpGaD
Esmolol—Dysgeusia—Topiramate—migraine	6.94e-05	0.00116	CcSEcCtD
Esmolol—Confusional state—Gabapentin—migraine	6.94e-05	0.00116	CcSEcCtD
Esmolol—Hypotension—Timolol—migraine	6.9e-05	0.00115	CcSEcCtD
Esmolol—Oedema—Gabapentin—migraine	6.88e-05	0.00115	CcSEcCtD
Esmolol—Feeling abnormal—Valproic Acid—migraine	6.84e-05	0.00114	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.81e-05	0.00265	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.78e-05	0.00264	CbGpPWpGaD
Esmolol—Shock—Gabapentin—migraine	6.77e-05	0.00113	CcSEcCtD
Esmolol—Nervous system disorder—Gabapentin—migraine	6.75e-05	0.00113	CcSEcCtD
Esmolol—Skin disorder—Gabapentin—migraine	6.68e-05	0.00112	CcSEcCtD
Esmolol—ADRB1—Signaling by GPCR—RAMP1—migraine	6.65e-05	0.00259	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CALCRL—migraine	6.65e-05	0.00259	CbGpPWpGaD
Esmolol—Hyperhidrosis—Gabapentin—migraine	6.65e-05	0.00111	CcSEcCtD
Esmolol—Paraesthesia—Timolol—migraine	6.63e-05	0.00111	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.63e-05	0.00258	CbGpPWpGaD
Esmolol—Urticaria—Valproic Acid—migraine	6.59e-05	0.0011	CcSEcCtD
Esmolol—Dyspnoea—Timolol—migraine	6.58e-05	0.0011	CcSEcCtD
Esmolol—Somnolence—Timolol—migraine	6.57e-05	0.0011	CcSEcCtD
Esmolol—Body temperature increased—Valproic Acid—migraine	6.56e-05	0.0011	CcSEcCtD
Esmolol—Anorexia—Gabapentin—migraine	6.56e-05	0.0011	CcSEcCtD
Esmolol—Agitation—Topiramate—migraine	6.52e-05	0.00109	CcSEcCtD
Esmolol—ADRB2—Signaling by GPCR—CALCRL—migraine	6.51e-05	0.00253	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RAMP1—migraine	6.51e-05	0.00253	CbGpPWpGaD
Esmolol—Dyspepsia—Timolol—migraine	6.5e-05	0.00109	CcSEcCtD
Esmolol—Hypotension—Gabapentin—migraine	6.43e-05	0.00108	CcSEcCtD
Esmolol—Decreased appetite—Timolol—migraine	6.42e-05	0.00107	CcSEcCtD
Esmolol—Gastrointestinal disorder—Timolol—migraine	6.38e-05	0.00107	CcSEcCtD
Esmolol—Fatigue—Timolol—migraine	6.37e-05	0.00107	CcSEcCtD
Esmolol—Syncope—Topiramate—migraine	6.36e-05	0.00106	CcSEcCtD
Esmolol—Pain—Timolol—migraine	6.32e-05	0.00106	CcSEcCtD
Esmolol—Loss of consciousness—Topiramate—migraine	6.23e-05	0.00104	CcSEcCtD
Esmolol—Paraesthesia—Gabapentin—migraine	6.18e-05	0.00103	CcSEcCtD
Esmolol—Convulsion—Topiramate—migraine	6.14e-05	0.00103	CcSEcCtD
Esmolol—Dyspnoea—Gabapentin—migraine	6.13e-05	0.00103	CcSEcCtD
Esmolol—Somnolence—Gabapentin—migraine	6.11e-05	0.00102	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.1e-05	0.00238	CbGpPWpGaD
Esmolol—Feeling abnormal—Timolol—migraine	6.09e-05	0.00102	CcSEcCtD
Esmolol—Dyspepsia—Gabapentin—migraine	6.05e-05	0.00101	CcSEcCtD
Esmolol—Chest pain—Topiramate—migraine	6.04e-05	0.00101	CcSEcCtD
Esmolol—Anxiety—Topiramate—migraine	6.02e-05	0.00101	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	5.99e-05	0.001	CcSEcCtD
Esmolol—Decreased appetite—Gabapentin—migraine	5.98e-05	0.001	CcSEcCtD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.97e-05	0.00232	CbGpPWpGaD
Esmolol—Asthenia—Valproic Acid—migraine	5.95e-05	0.000996	CcSEcCtD
Esmolol—Gastrointestinal disorder—Gabapentin—migraine	5.94e-05	0.000993	CcSEcCtD
Esmolol—Fatigue—Gabapentin—migraine	5.93e-05	0.000992	CcSEcCtD
Esmolol—Dry mouth—Topiramate—migraine	5.9e-05	0.000988	CcSEcCtD
Esmolol—Pain—Gabapentin—migraine	5.88e-05	0.000984	CcSEcCtD
Esmolol—Constipation—Gabapentin—migraine	5.88e-05	0.000984	CcSEcCtD
Esmolol—Pruritus—Valproic Acid—migraine	5.87e-05	0.000982	CcSEcCtD
Esmolol—Urticaria—Timolol—migraine	5.87e-05	0.000982	CcSEcCtD
Esmolol—Body temperature increased—Timolol—migraine	5.84e-05	0.000977	CcSEcCtD
Esmolol—Confusional state—Topiramate—migraine	5.83e-05	0.000976	CcSEcCtD
Esmolol—Oedema—Topiramate—migraine	5.79e-05	0.000968	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR1B—migraine	5.71e-05	0.00222	CbGpPWpGaD
Esmolol—Shock—Topiramate—migraine	5.69e-05	0.000952	CcSEcCtD
Esmolol—Nervous system disorder—Topiramate—migraine	5.67e-05	0.000949	CcSEcCtD
Esmolol—Feeling abnormal—Gabapentin—migraine	5.67e-05	0.000948	CcSEcCtD
Esmolol—Skin disorder—Topiramate—migraine	5.62e-05	0.00094	CcSEcCtD
Esmolol—Hyperhidrosis—Topiramate—migraine	5.59e-05	0.000936	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR1B—migraine	5.58e-05	0.00217	CbGpPWpGaD
Esmolol—Anorexia—Topiramate—migraine	5.52e-05	0.000923	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR1A—migraine	5.49e-05	0.00214	CbGpPWpGaD
Esmolol—Dizziness—Valproic Acid—migraine	5.49e-05	0.000918	CcSEcCtD
Esmolol—Urticaria—Gabapentin—migraine	5.46e-05	0.000914	CcSEcCtD
Esmolol—Body temperature increased—Gabapentin—migraine	5.44e-05	0.00091	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—TAC1—migraine	5.41e-05	0.00211	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—NPS—migraine	5.41e-05	0.00211	CbGpPWpGaD
Esmolol—Hypotension—Topiramate—migraine	5.41e-05	0.000905	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR1A—migraine	5.37e-05	0.00209	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	5.32e-05	0.00207	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—HTR2C—migraine	5.3e-05	0.00207	CbGpPWpGaD
Esmolol—Asthenia—Timolol—migraine	5.3e-05	0.000887	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—TAC1—migraine	5.29e-05	0.00206	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—NPS—migraine	5.29e-05	0.00206	CbGpPWpGaD
Esmolol—Vomiting—Valproic Acid—migraine	5.28e-05	0.000883	CcSEcCtD
Esmolol—Pruritus—Timolol—migraine	5.23e-05	0.000874	CcSEcCtD
Esmolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	5.21e-05	0.00203	CbGpPWpGaD
Esmolol—Headache—Valproic Acid—migraine	5.2e-05	0.00087	CcSEcCtD
Esmolol—Paraesthesia—Topiramate—migraine	5.2e-05	0.000869	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR2C—migraine	5.19e-05	0.00202	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—EDNRA—migraine	5.16e-05	0.00201	CbGpPWpGaD
Esmolol—Dyspnoea—Topiramate—migraine	5.16e-05	0.000863	CcSEcCtD
Esmolol—Somnolence—Topiramate—migraine	5.14e-05	0.000861	CcSEcCtD
Esmolol—Dyspepsia—Topiramate—migraine	5.09e-05	0.000852	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—EDNRA—migraine	5.05e-05	0.00197	CbGpPWpGaD
Esmolol—Decreased appetite—Topiramate—migraine	5.03e-05	0.000842	CcSEcCtD
Esmolol—Gastrointestinal disorder—Topiramate—migraine	5e-05	0.000836	CcSEcCtD
Esmolol—Fatigue—Topiramate—migraine	4.99e-05	0.000835	CcSEcCtD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.99e-05	0.00194	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CALCA—migraine	4.97e-05	0.00193	CbGpPWpGaD
Esmolol—Constipation—Topiramate—migraine	4.95e-05	0.000828	CcSEcCtD
Esmolol—Pain—Topiramate—migraine	4.95e-05	0.000828	CcSEcCtD
Esmolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	4.95e-05	0.00193	CbGpPWpGaD
Esmolol—Asthenia—Gabapentin—migraine	4.93e-05	0.000826	CcSEcCtD
Esmolol—Nausea—Valproic Acid—migraine	4.93e-05	0.000824	CcSEcCtD
Esmolol—Dizziness—Timolol—migraine	4.88e-05	0.000817	CcSEcCtD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.88e-05	0.0019	CbGpPWpGaD
Esmolol—Pruritus—Gabapentin—migraine	4.87e-05	0.000814	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—CALCA—migraine	4.86e-05	0.00189	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	4.84e-05	0.00188	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR1D—migraine	4.83e-05	0.00188	CbGpPWpGaD
Esmolol—Feeling abnormal—Topiramate—migraine	4.77e-05	0.000798	CcSEcCtD
Esmolol—ADRB2—Signaling by GPCR—HTR1D—migraine	4.73e-05	0.00184	CbGpPWpGaD
Esmolol—Vomiting—Timolol—migraine	4.7e-05	0.000786	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR7—migraine	4.65e-05	0.00181	CbGpPWpGaD
Esmolol—Headache—Timolol—migraine	4.63e-05	0.000774	CcSEcCtD
Esmolol—Urticaria—Topiramate—migraine	4.6e-05	0.000769	CcSEcCtD
Esmolol—Body temperature increased—Topiramate—migraine	4.57e-05	0.000765	CcSEcCtD
Esmolol—Dizziness—Gabapentin—migraine	4.55e-05	0.000761	CcSEcCtD
Esmolol—ADRB2—GPCR ligand binding—HTR7—migraine	4.54e-05	0.00177	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR2B—migraine	4.49e-05	0.00175	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR2B—migraine	4.39e-05	0.00171	CbGpPWpGaD
Esmolol—Nausea—Timolol—migraine	4.39e-05	0.000734	CcSEcCtD
Esmolol—Vomiting—Gabapentin—migraine	4.37e-05	0.000732	CcSEcCtD
Esmolol—Headache—Gabapentin—migraine	4.31e-05	0.000721	CcSEcCtD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.27e-05	0.00166	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.18e-05	0.00163	CbGpPWpGaD
Esmolol—Asthenia—Topiramate—migraine	4.15e-05	0.000695	CcSEcCtD
Esmolol—Pruritus—Topiramate—migraine	4.09e-05	0.000685	CcSEcCtD
Esmolol—Nausea—Gabapentin—migraine	4.09e-05	0.000683	CcSEcCtD
Esmolol—ADRB1—Signaling Pathways—RAMP1—migraine	3.93e-05	0.00153	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALCRL—migraine	3.93e-05	0.00153	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALCRL—migraine	3.84e-05	0.0015	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RAMP1—migraine	3.84e-05	0.0015	CbGpPWpGaD
Esmolol—Dizziness—Topiramate—migraine	3.83e-05	0.00064	CcSEcCtD
Esmolol—Vomiting—Topiramate—migraine	3.68e-05	0.000616	CcSEcCtD
Esmolol—Headache—Topiramate—migraine	3.63e-05	0.000606	CcSEcCtD
Esmolol—Nausea—Topiramate—migraine	3.44e-05	0.000575	CcSEcCtD
Esmolol—ADRB1—GPCR ligand binding—HTR2A—migraine	3.25e-05	0.00127	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	3.22e-05	0.00126	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—HTR2A—migraine	3.18e-05	0.00124	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	3.15e-05	0.00123	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	3.1e-05	0.00121	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—TAC1—migraine	3.06e-05	0.00119	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—NPS—migraine	3.06e-05	0.00119	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	3.04e-05	0.00118	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	3e-05	0.00117	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—TAC1—migraine	2.99e-05	0.00116	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—NPS—migraine	2.99e-05	0.00116	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	2.93e-05	0.00114	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR1B—migraine	2.93e-05	0.00114	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	2.92e-05	0.00114	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.86e-05	0.00112	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.85e-05	0.00111	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.85e-05	0.00111	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2.82e-05	0.0011	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CALCA—migraine	2.81e-05	0.00109	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR1D—migraine	2.79e-05	0.00109	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—TAC1—migraine	2.78e-05	0.00108	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—NPS—migraine	2.78e-05	0.00108	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR1A—migraine	2.76e-05	0.00107	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CALCA—migraine	2.75e-05	0.00107	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR2C—migraine	2.72e-05	0.00106	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—TAC1—migraine	2.72e-05	0.00106	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—NPS—migraine	2.72e-05	0.00106	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR2C—migraine	2.66e-05	0.00104	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2B—migraine	2.65e-05	0.00103	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDNRA—migraine	2.65e-05	0.00103	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR7—migraine	2.63e-05	0.00102	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2B—migraine	2.6e-05	0.00101	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDNRA—migraine	2.59e-05	0.00101	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR7—migraine	2.57e-05	0.001	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CALCA—migraine	2.55e-05	0.000992	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CALCA—migraine	2.49e-05	0.000971	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR7—migraine	2.38e-05	0.000928	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LRP1—migraine	2.34e-05	0.00091	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR7—migraine	2.33e-05	0.000908	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LRP1—migraine	2.29e-05	0.00089	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.84e-05	0.000716	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.8e-05	0.0007	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.79e-05	0.000698	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.75e-05	0.000683	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.73e-05	0.000673	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.69e-05	0.000659	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.67e-05	0.00065	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.66e-05	0.000648	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PGR—migraine	1.64e-05	0.000638	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TAC1—migraine	1.64e-05	0.000638	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NPS—migraine	1.64e-05	0.000638	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.63e-05	0.000636	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.63e-05	0.000634	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.61e-05	0.000626	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PGR—migraine	1.6e-05	0.000624	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NPS—migraine	1.6e-05	0.000624	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TAC1—migraine	1.6e-05	0.000624	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.57e-05	0.000612	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.56e-05	0.000609	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.53e-05	0.000596	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.52e-05	0.000593	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALCA—migraine	1.51e-05	0.000586	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.49e-05	0.000581	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALCA—migraine	1.47e-05	0.000573	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR7—migraine	1.41e-05	0.000548	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR7—migraine	1.38e-05	0.000536	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFBR2—migraine	1.21e-05	0.000472	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFBR2—migraine	1.19e-05	0.000462	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2A—migraine	9.86e-06	0.000384	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2A—migraine	9.65e-06	0.000376	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—migraine	8.75e-06	0.000341	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—migraine	8.56e-06	0.000333	CbGpPWpGaD
